# Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

> **NCT04569409** · PHASE3 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 104 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** ALLO-ASC-DFU
- **PROCEDURE:** Vehicle Sheet

## Key facts

- **NCT ID:** NCT04569409
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-14
- **Primary completion:** 2024-12-05
- **Final completion:** 2024-12-05
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04569409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04569409, "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04569409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*